Nucleix
Olga Antonova has a wealth of work experience, starting in 2011 as a Research Assistant at the Research Institute of Molecular Pathology (IMP). In 2012, they began working as a Geneticist at Max F. Perutz Laboratories. In 2017, they were a Research Assistant at Tel Aviv University. In 2021, they began working as a Scientist at R&D Genomics for the Merck Group. Most recently, they have been a Product Development Scientist at Nucleix Ltd. since 2022.
Olga Antonova obtained their Master's degree in Biology from Novosibirsk State University (NSU) between 2005 and 2010. Additionally, they have obtained two certifications from LinkedIn, "Communicating with Confidence" in June 2021 and "Creative Inspirations: Ed Emberley, Children's Book Illustrator" in April 2021.
This person is not in any offices
Nucleix
Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic biomarkers. Backed by OrbiMed and other leading investors, Nucleix provides a strong pipeline of products for various cancer types.